A study of Tolvaptan to investigate the pharmacokinetics and diuretic effect
Not Applicable
- Conditions
- congestive heart failure
- Registration Number
- JPRN-UMIN000006726
- Lead Sponsor
- Kanagawa Children's Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. patients who have circulation assist 2. patients who have diseases, complications or symptoms as follows: *possibly hypovolemic *hypertrophic cardiomyopathy *hepatic coma *severe diabetes *anuria *urinary stenosis, calculus or impairment of urinary excretion due to tumor 3. patients who have a history as follows: *cerebrovascular disease (asymptomatic is excluded) *patients who have a history of allergy against benzazepine 4. patients whose laboratory test are as follows(at least 1 item) *total bilirubin >3.0mg/dL *serum creatinine >3.0mg/dL *serum Na >147mEq/L *serum K >5.5mEq/L 5. patients who are judged to be inappropriate to this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method